ILMN insider trading

NasdaqGS Healthcare

ILLUMINA, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
2,200
Last 90 days
55
Buys / sells
1% / 57%
Market cap
$18.81B

About ILLUMINA, INC.

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Company website: www.illumina.com

ILMN insider activity at a glance

FilingIQ has scored 2,200 insider transactions for ILMN since Jan 22, 2014. The most recent filing in our index is dated May 14, 2026.

Across the full history, 13 open-market purchases and 1,251 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ILMN insider trades is 56.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ILMN Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

13F funds holding ILMN

Politicians who have traded ILMN

Frequently asked

How many insider trades does FilingIQ track for ILMN?
FilingIQ tracks 2,200 Form 4 insider transactions for ILMN (ILLUMINA, INC.), covering filings from Jan 22, 2014 onwards. 55 of those were filed in the last 90 days.
Are ILMN insiders net buyers or net sellers?
Across the full Form 4 history for ILMN, 13 transactions (1%) were open-market purchases and 1,251 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ILMN insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ILMN in?
ILLUMINA, INC. (ILMN) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $18.81B.

Methodology & sources

Every ILMN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.